首页 | 本学科首页   官方微博 | 高级检索  
检索        

心脏再同步化治疗心力衰竭伴传导阻滞患者的近期随访
引用本文:张学芳%张高星%彭宇程%孙刚%刘金学.心脏再同步化治疗心力衰竭伴传导阻滞患者的近期随访[J].中国心血管病研究杂志,2014(9):825-828.
作者姓名:张学芳%张高星%彭宇程%孙刚%刘金学
作者单位:江门市中心医院心内科,广东省江门市529030
摘    要:目的 观察心脏再同步化治疗(CRT)心力衰竭伴传导阻滞患者心功能改善情况.方法 连续入选在我科住院的终末期心力衰竭患者45例,按照QRS时限、形态分为完全性左束支传导阻滞组、完全性右束支传导阻滞组和非特异性室内传导阻滞组,分别评估、测量三组患者术前及术后6个月的NYHA分级、左室舒张末内径(LVED)、左室射血分数(LVEF)及血浆B型利钠肽(BNP)浓度.结果 完全性左束支传导阻滞组和非特异性室内传导阻滞组患者术后NYHA分级改善(2.8±0.3)级比(3.6±0.2)级,(2.9±0.3)级比(3.5±0.4)级,P<0.05],LVED缩小(67.2±7.5)mm比(74.2±6.5)mm,(66.4±9.9)mm比(75.8±9.1)mm,P<0.05],LVEF增大(33.6±7.7)%比(26.6±7.2)%,(44.4±5.1)%比(28.6±5.7)%,P<0.05],血浆BNP浓度下降(3988.4±628.3)pg/ml比(8542.6±1384.9)pg/ml,(3573.2±749.5)pg/ml比(6666.2±1110.5)pg/ml,P<0.05];完全性右束支传导阻滞组NYHA分级没有改善(3.3±0.2)级比(3.4±0.3)级,P>0.05],LVED无变化(61.2±5.0)mm比(62.4±4.3)mm,P>0.05],LVEF没有增大(35.2±12.3)%比(33.4±11.8)%,P>0.05],血浆BNP浓度无明显变化(6844.7±774.8)pg/ml比(7558.6±1327.4)pg/ml,P>0.05].结论 心脏再同步化治疗能够改善完全性左束支传导阻滞及非特异性室内传导阻滞患者的心脏功能,不能改善完全性右束支传导阻滞患者的心脏功能.

关 键 词:心脏再同步化治疗  传导阻滞  心功能  B型利钠肽

The effect of cardiac resynchronization therapy in heart failure patients with conduction block
Institution:ZHANG Xue-fang(Department of Cardiology, Jiangmen Central Hospital , Jiangmen 529030, China) ZHANG Gao-xing(Department of Cardiology, Jiangmen Central Hospital , Jiangmen 529030, China) PENG Yu-cheng(Department of Cardiology, Jiangmen Central Hospital , Jiangmen 529030, China)
Abstract:Objective To evaluate the effect of cardiac resynchronization therapy in heart failure patients with complete left bundle-branch block,complete right bundle-branch block,and non-specific intraventricular conduction block.Methods CRT was implanted in forty-five heart failure patients,according to QRS,the patients were divided into complete left bundle-branch block group,complete right bundle-branch block and nonspecific intraventricular conduction block group.NYHA grade,left ventricular diastolic diameter(LVED),left ventricular ejection fraction(LVEF) and B-type natriuretic peptides (BNP) of the three group patients were evaluated before cardiac resynchronization therapy and six months after cardiac resynchronization therapy.Results In the complete left bundle-branch block group and non-specific intraventricular conduction block group,after cardiac resynchronization therapy,NYHA grade improved significantly (3.6±0.2) vs (2.8±0.3),(3.5±0.4) vs (2.9± 0.3),P〈0.05],LVED become smaller (74.2±6.5)mm vs (67.2±7.5)mm,(75.8±9.1)mm vs (66.4±9.9)mm,P〈0.05],LVEF also improved(26.6±7.2)% vs (33.6±7.7)%,(28.6±5.7)% vs (44.4±5.1)%,P〈0.05],BNP decreased significantly (8542.6 ± 1384.9)pg/ml vs (3988.4 ±628.3)pg/ml,(6666.2 ± 1110.5)pg/ml vs (3573.2 ± 749.5)pg/ml,P〈0.05].However,in the complete right bundle-branch block group,NYHA grade was not improved (3.4±0.3) vs (3.3±0.2),P〉0.05],LVED do not become smaller (62.4±4.3)mm vs (61.2±5.0)mm,P〉0.05],LVEF was not improved (33.4±11.8)% vs (35.2±12.3)%,P〉0.05],and BNP was not decreased (7558.6±1327.4)pg/ml vs (6844.7±774.8)pg/ml,P〉0.05].Conclusion Cardiac resynchronization therapy could improve left ventricular function in complete left bundle-branch block patients and non-specific intraventricular conduction block patients,however,left ventricular function of complete right bundle-branch block patients were not improved after cardiac
Keywords:Cardiac resynchronization therapy  Conduction block  Left ventricular function  B-type natriuretic peptides
本文献已被 维普 等数据库收录!
点击此处可从《中国心血管病研究杂志》浏览原始摘要信息
点击此处可从《中国心血管病研究杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号